Stock Information
Autolus Therapeutics PLC (AUTL)
Ticker Symbol: AUTL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $420.51 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.0803
Revenue (TTM): $0.28 M
Dividend Yield: N/A%
ROE: -99.05%
Latest News
-
Autolus Therapeutics plc (AUTL) Q1 2026 Earnings Call Transcript
Thu, May 14, 2026 8:10 PM
-
Transcript : Autolus Therapeutics plc, Q1 2026 Earnings Call, May 14, 2026
Thu, May 14, 2026 3:35 PM
-
Autolus Therapeutics plc 2026 Q1 - Results - Earnings Call Presentation
Thu, May 14, 2026 3:34 PM
-
HC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10
Thu, May 14, 2026 1:35 PM
-
Autolus Therapeutics (NASDAQ:AUTL) Posts Inline Q1 Results with First Positive Gross Margin, but Full-Year Guidance Slightly Below Consensus
Thu, May 14, 2026 12:24 PM
-
Autolus Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript
Thu, May 14, 2026 9:42 AM
-
Autolus Therapeutics Sees FY2026 Sales $120.000M-$135.000M vs $130.062M Est
Thu, May 14, 2026 8:58 AM
-
Autolus Therapeutics Q1 EPS $(0.27), Inline, Sales $26.218M Beat $26.160M Estimate
Thu, May 14, 2026 7:12 AM
-
Earnings Scheduled For May 14, 2026
Thu, May 14, 2026 7:11 AM
-
Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
Thu, May 14, 2026 7:03 AM
Key Financials
Financial data not available
